Crosstalk between Toll like receptors and C5a receptor in human monocyte derived DCs suppress inflammatory cytokine production

Immunobiology

Volumn 218, Issue 2, 2013, Pages 175-180

  Zaal, Anouk ^a   Lissenberg Thunnissen, Suzanne N ^a   van Schijndel, Gijs ^a   Wouters, Diana ^a   van Ham, S Marieke ^a   ten Brinke, Anja ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Anaphylatoxins; C5a; Cytokines; Dendritic cells; Human; Toll like receptor

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RESIQUIMOD; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL INTERACTION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR DOWN REGULATION;

CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HUMANS; IMIDAZOLES; IMMUNE TOLERANCE; INFLAMMATION MEDIATORS; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MONOCYTES; RECEPTOR CROSS-TALK; RECEPTORS, COMPLEMENT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84871927877     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.02.014     Document Type: Article

References (26)

1. Braun M.C., Lahey E., Kelsall B.L. Selective suppression of IL-12 production by chemoattractants. J. Immunol. 2000, 164:3009-3017.
2. de Wit J., et al. Antigen-specific B cells reactivate an effective cytotoxic T cell response against phagocytosed Salmonella through cross-presentation. PLoS One 2010, 5:e13016.
3. Emlen W., Li W., Kirschfink M. Therapeutic complement inhibition: new developments. Semin. Thromb. Hemost. 2010, 36:660-668.
4. Fang C., Zhang X., Miwa T., Song W.C. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 2009, 114:1005-1015.
5. Hawlisch H., et al. C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 2005, 22:415-426.
6. Kildsgaard J., et al. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J. Immunol. 2000, 165:5406-5409.
7. la Sala A., Gadina M., Kelsall B.L. G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. J. Immunol. 2005, 175:2994-2999.
8. Lalli P.N., Strainic M.G., Lin F., Medof M.E., Heeger P.S. Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production. J. Immunol. 2007, 179:5793-5802.
9. Lewis A.G., Kohl G., Ma Q., Devarajan P., Kohl J. Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival. Clin. Exp. Immunol. 2008, 153:117-126.
10. Li K., et al. Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology 2012, 217:65-73.
11. Li K., et al. Expression of complement components, receptors and regulators by human dendritic cells. Mol. Immunol. 2011, 48:1121-1127.
12. Okazaki N., Hazeki K., Izumi T., Nigorikawa K., Hazeki O. C5a controls TLR-induced IL-10 and IL-12 production independent of phosphoinositide 3-kinase. J. Biochem. 2011, 149:265-274.
13. Peng Q., et al. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 2008, 111:2452-2461.
14. Peng Q., Li K., Patel H., Sacks S.H., Zhou W. Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J. Immunol. 2006, 176:3330-3341.
15. Peng Q., et al. Dendritic cell function in allostimulation is modulated by C5aR signaling. J. Immunol. 2009, 183:6058-6068.
16. Pratt J.R., Basheer S.A., Sacks S.H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 2002, 8:582-587.
17. Qu H., Ricklin D., Lambris J.D. Recent developments in low molecular weight complement inhibitors. Mol. Immunol. 2009, 47:185-195.
18. Reis E.S., Barbuto J.A., Isaac L. Human monocyte-derived dendritic cells are a source of several complement proteins. Inflamm. Res. 2006, 55:179-184.
19. Soruri A., et al. IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo. J. Immunol. 2003, 170:3306-3314.
20. Strainic M.G., et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 2008, 28:425-435.
21. Ten Brinke A., Karsten M.L., Dieker M.C., Zwaginga J.J., van Ham S.M. The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization. Vaccine 2007, 25:7145-7152.
22. Ten Brinke A., et al. Generation of dendritic cells for immunotherapy is minimally impaired by granulocytes in the monocyte preparation. Immunobiology 2006, 211:633-640.
23. Wang M., et al. Microbial hijacking of complement-toll-like receptor crosstalk. Sci. Signal. 2010, 3:ra11.
24. Weinmann O., et al. Up-regulation of C5a receptor expression and function on human monocyte derived dendritic cells by prostaglandin E2. Immunology 2003, 110:458-465.
25. Wittmann M., et al. C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J. Immunol. 1999, 162:6763-6769.
26. Zhang X., et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 2007, 110:228-236.